Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
Hematology, University Tor Vergata, St. Eugenio Hospital, Rome, Italy.
Paolo
P
De Fabritiis
Teresa
T
Dentamaro
Alessandra
A
Picardi
Laura
L
Cudillo
Mario
M
Masi
Sergio
S
Amadori
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D004341:Drug Evaluation; D015942:Factor VIIa / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000150:complications; D019337:Hematologic Neoplasms / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D017713:Platelet Transfusion; D011994:Recombinant Proteins / Q000627:therapeutic use; D016896:Treatment Outcome
D011994:Recombinant Proteins; D015942:Factor VIIa